The Bleeding Edge, Part 3

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we conclude our conversation on the Netflix documentary, The Bleeding Edge. The documentary presents harsh criticism of the industry in terms of how devices are approved and what is done when problems arise. Throughout all three parts of this podcast series, we highlight a good number of points brought up in the documentary and analyze whether each is a fair criticism or not. Discussion topics in this third and final part include:  The dismissal of nine reviewers from the FDA who brought up concerns regarding certain processes and products.The lobbying power of the medtech and pharma sectors.The call for less innovation by several people in the documentary.A J&J executive admitting on film during a deposition that they were aware of issues with their mesh product.The observation that doctors seemed to require more evidence to abandon a product they were using then it took to initially have it approved.The money paid to doctors by the medtech industry.Before listening to the podcast, it would be best to view the documentary via Netflix. Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify. Once you’ve had a chance to listen to the podcast, if you have any questions or comments you’d like us to discuss or share with other Mike on Medtech listeners about this topic or any other topic we’ve addressed, or you have a suggestion for a future topic for us to cover, email me at [email protected] and we’ll try to respond in an upcoming Mike on Medtech podcast.Send us Fan Mail For more medtech news and information, visit https://www.mpomag.com.